Thr655

Site Information
ssDPLGDtASNLGSA SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 4743319

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 )
Disease tissue studied:	gastric cancer ( 2 , 3 , 4 , 5 ) , gastric carcinoma ( 2 , 3 , 4 , 5 ) , lymphoma ( 1 ) , Burkitt's lymphoma ( 1 ) , follicular lymphoma ( 1 ) , mantle cell lymphoma ( 1 )
Relevant cell line - cell type - tissue:	FL-318 (B lymphocyte) ( 1 ) , HeLa (cervical) ( 6 ) , JEKO-1 (B lymphocyte) ( 1 ) , MKN-45 (gastric) ( 2 , 3 , 4 , 5 ) , Raji (B lymphocyte) ( 1 )

References
1	Rolland D, et al. (2014) Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas. Am J Pathol 184, 1331-42 24667141 Curated Info
2	Moritz A (2011) CST Curation Set: 11934; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Curated Info
3	Moritz A (2011) CST Curation Set: 11935; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Curated Info
4	Moritz A (2011) CST Curation Set: 11938; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Curated Info
5	Moritz A (2011) CST Curation Set: 11944; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Curated Info
6	Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5 21712546 Curated Info